Final Analysis of a Randomized Phase III Trial of Accelerated versus Conventional Fractionation Radiotherapy for Glottic Cancer of T1-2N0M0 (JCOG0701)

被引：1

作者：

Kodaira, T. ^{[1
]}

Kagami, Y. ^{[2
]}

Shibata, T. ^{[3
]}

Shikama, N. ^{[4
]}

Hiraoka, M. ^{[5
]}

Nishimura, Y. ^{[6
]}

Ishikura, S. ^{[7
]}

Nakamura, K. ^{[3
]}

Saito, Y. ^{[8
]}

Matsumoto, Y. ^{[9
]}

Konishi, K. ^{[10
]}

Ito, Y. ^{[11
]}

Akimoto, T. ^{[12
]}

Nakata, K. ^{[13
]}

Toshiyasu, T. ^{[14
]}

Nakagawa, K. ^{[15
]}

Nagata, Y. ^{[16
]}

Nishimura, T. ^{[17
]}

Uno, T. ^{[18
]}

Kataoka, M. ^{[19
]}

机构：

[1] Aichi Canc Ctr Hosp, Dept Radiat Oncol, Nagoya, Aichi, Japan

[2] Showa Univ Hosp, Dept Radiat Oncol, Shinagawa Ku, Tokyo, Japan

[3] Natl Canc Ctr, Japan Clin Oncol Grp Data Ctr, Operat Off, Tokyo, Japan

[4] Saitama Med Univ, Int Med Ctr, Dept Radiol Oncol, Hidaka City, Japan

[5] Kyoto Univ, Dept Radiat Oncol & Image Appl Therapy, Grad Sch Med, Kyoto, Japan

[6] Kindai Univ, Dept Radiat Oncol, Fac Med, Osaka, Japan

[7] Koshigaya Municipal Hosp, Dept Radiol, Koshigaya, Japan

[8] Saitama Canc Ctr, Dept Radiat Oncol, Saitama, Japan

[9] Niigata Canc Ctr Hosp, Dept Radiat Oncol, Niigata, Japan

[10] Osaka Med Ctr Canc & Cardiovasc Dis, Dept Radiat Oncol, Osaka, Japan

[11] Natl Canc Ctr, Dept Radiat Oncol, Tokyo, Japan

[12] Natl Canc Ctr Hosp East, Div Radiat Oncol & Particle Therapy, Kashiwa, Chiba, Japan

[13] Sapporo Med Univ, Dept Radiol, Sapporo, Hokkaido, Japan

[14] JFCR, Dept Radiat Oncol, Canc Inst Hosp, Tokyo, Japan

[15] Tokyo Univ Hosp, Dept Radiol, Tokyo, Japan

[16] Hiroshima Univ Hosp, Dept Radiat Oncol, Hiroshima, Japan

[17] Shizuoka Canc Ctr, Div Radiat Oncol, Shizuoka, Japan

[18] Chiba Univ, Grad Sch Med, Diagnost Radiol & Radiat Oncol, Chiba, Japan

[19] Shikoku Canc Ctr, Dept Radiat Oncol, Shikoku, Ehime, Japan

来源：

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2016年 / 96卷 / 05期

关键词：

D O I：

10.1016/j.ijrobp.2016.09.052

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

LBA-8

引用

页码：940 / 940

页数：1

共 50 条

[1] Accelerated fractionation versus conventional fractionation radiation therapy for glottic cancer of T1-2N0M0 phase III study: Japan clinical oncology group study (JCOG 0701)
Nakamura, Kenichi
Kodaira, Takeshi
Shikama, Naoto
Kagami, Yoshikazu
Ishikura, Satoshi
Shibata, Taro
Hiraoka, Masahiro
[J]. JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2008, 38 (05) : 387 - 389
[2] Results of a multi-institutional, randomized, non-inferiority, phase III trial of accelerated fractionation versus standard fractionation in radiation therapy for T1-2N0M0 glottic cancer: Japan Clinical Oncology Group Study JCOG0701)
Kodaira, T.
Kagami, Y.
Shibata, T.
Shikama, N.
Nishimura, Y.
Ishikura, S.
Nakamura, K.
Saito, Y.
Matsumoto, Y.
Teshima, T.
Ito, Y.
Akimoto, T.
Nakata, K.
Toshiyasu, T.
Nakagawa, K.
Nagata, Y.
Nishimura, T.
Uno, T.
Kataoka, M.
Yorozu, A.
Hiraoka, M.
[J]. ANNALS OF ONCOLOGY, 2018, 29 (04) : 992 - 997
[3] Hypofractionated radiotherapy versus conventional radiotherapy in early glottic cancer T1-2N0M0: A randomized study
Kachhwaha, Avni
Jakhar, Shankar Lal
Syiem, Tanya
Sharma, Neeti
Kumar, Harvinder Singh
Sharma, Ajay
[J]. JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2021, 17 (06) : 1499 - 1502
[4] Prognostic Value of Epithelial Cell Adhesion Molecules in T1-2N0M0 Glottic Cancer
Murakami, Naoya
Mori, Taisuke
Machida, Ryunosuke
Kodaira, Takeshi
Ito, Yoshinori
Shikama, Naoto
Konishi, Koji
Matsumoto, Yasuo
Murakami, Yuji
Nakamura, Naoki
Yamashita, Hideomi
Yorozu, Atsunori
Yoshimura, Michio
Inoue, Koichi
Nozaki, Miwako
Ishikura, Satoshi
Itami, Jun
Nishimura, Yasumasa
Kagami, Yoshikazu
[J]. LARYNGOSCOPE, 2021, 131 (07): : 1522 - 1527
[5] Chemoradiation or Altered Fractionation for T2N0M0 Glottic Cancer
Ahamad, A.
Salenius, S.
Ross, R.
Selvaraj, R. N.
Fernandez, E.
[J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 102 (03): : E201 - E201
[6] Fractionation Patterns for Patients With T2N0M0 Glottic Cancer Undergoing Definitive Radiotherapy: A National Cancer Database Analysis
Stokes, William A.
Lanning, Ryan M.
Karam, Sana D.
Raben, David
[J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 98 (02): : E32 - E32
[7] PET/CT findings and dose distribution during radiotherapy in T1N0M0-T2N0M0 glottic cancer
Okada, Yukinori
Zama, Tatsuhiko
Itonaga, Tomohiro
Mikami, Ryuji
Okubo, Mitsuru
Sugahara, Shinji
Kurooka, Masahiko
Nakai, Motoki
Abe, Koichiro
Yoshimura, Mana
Saito, Kazuhiro
[J]. HELLENIC JOURNAL OF NUCLEAR MEDICINE, 2024, 27 (01) : 27 - 34
[8] PROGNOSTIC FACTORS FOR THE PATIENTS WITH T1-2N0M0 BREAST CANCER
Cetintas, S. Kahraman
Ozkan, L.
Kurt, S.
Kurt, M.
Kartal, C.
Tasdelen, I.
[J]. RADIOTHERAPY AND ONCOLOGY, 2008, 88 : S201 - S202
[9] Stereotactic ablative radiotherapy for inoperable T1-2N0M0 small-cell lung cancer
Tang, Hui
Liu, Wei
Huang, Kaiming
[J]. THORACIC CANCER, 2022, 13 (07) : 1100 - 1101
[10] Patterns of fractionation for patients with T2N0M0 glottic larynx cancer undergoing definitive radiotherapy in the United States
Stokes, William A.
Stumpf, Priscilla K.
Jones, Bernard L.
Blatchford, Patrick J.
Karam, Sana D.
Lanning, Ryan M.
Raben, David
[J]. ORAL ONCOLOGY, 2017, 72 : 110 - 116

← 1 2 3 4 5 →